ZNF552 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.921800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.634400E-01
Normal-vs-Stage2
6.625400E-01
Normal-vs-Stage3
1.482780E-01
Normal-vs-Stage4
7.226000E-01
Stage1-vs-Stage2
4.915000E-01
Stage1-vs-Stage3
3.274800E-01
Stage1-vs-Stage4
7.308400E-01
Stage2-vs-Stage3
3.905000E-01
Stage2-vs-Stage4
2.360600E-01
Stage3-vs-Stage4
2.655600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.614200E-01
Normal-vs-AfricanAmerican
2.830000E-01
Normal-vs-Asian
8.796000E-01
Caucasian-vs-AfricanAmerican
6.540800E-01
Caucasian-vs-Asian
3.815600E-01
AfricanAmerican-vs-Asian
3.893400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.309600E-01
Normal-vs-Female
5.596000E-01
Male-vs-Female
7.451800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.458600E-01
Normal-vs-Age(41-60Yrs)
8.625800E-01
Normal-vs-Age(61-80Yrs)
4.470600E-01
Normal-vs-Age(81-100Yrs)
3.783200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.164600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.892400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.458600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.999950E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.892600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.047000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.466600E-01
Normal-vs-Daily Drinker
3.961800E-01
Normal-vs-Weekly Drinker
3.665600E-01
Normal-vs-Occasional Drinker
9.707600E-01
Normal-vs-Social Drinker
5.873000E-01
Non Drinker-vs-Daily Drinker
8.922800E-01
Non Drinker-vs-Weekly Drinker
8.981600E-01
Non Drinker-vs-Occasional Drinker
3.185200E-01
Non Drinker-vs-Social Drinker
6.147800E-01
Daily Drinker-vs-Weekly Drinker
9.890200E-01
Daily Drinker-vs-Occasional Drinker
2.824200E-01
Daily Drinker-vs-Social Drinker
4.612800E-01
Weekly Drinker-vs-Occasional Drinker
2.964000E-01
Weekly Drinker-vs-Social Drinker
4.716000E-01
Occasional Drinker-vs-Social Drinker
5.818400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.304200E-01
Normal-vs-Grade 2
9.776000E-02
Normal-vs-Grade 3
7.209600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.322400E-01
Grade 1-vs-Grade 3
3.835600E-01
Grade 1-vs-Grade 4
2.304200E-01
Grade 2-vs-Grade 3
9.633800E-01
Grade 2-vs-Grade 4
9.776000E-02
Grade 3-vs-Grade 4
7.209600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.823600E-01
Normal-vs-NonDiabetic
5.393800E-01
Diabetic-vs-NonDiabetic
6.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.857000E-01
Normal-vs-NoPancreatitis
5.349200E-01
Pancreatitis-vs-NoPancreatitis
8.390200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.098800E-01
Normal-vs-N1
5.392200E-01
N0-vs-N1
9.015400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.348200E-01
Normal-vs-TP53-NonMutant
8.044800E-01
TP53-Mutant-vs-TP53-NonMutant
2.740200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
